409A Valuation Audit Review: 10 Questions Auditors Ask and How to Prepare

Completing a 409A valuation is an important step for a private company issuing stock options—but obtaining the valuation report may not be the end of the process.

The valuation may later be examined during a financial statement audit, stock-based compensation review, financing, transaction, due diligence process, or another professional review.

At that point, reviewers are unlikely to focus only on the final fair market value per share.

They may want to understand how the valuation conclusion was developed and whether the underlying assumptions are reasonable, consistent, and adequately documented.

Typical questions may include:

• How was the latest preferred financing considered?
• Why was OPM, PWERM, or another allocation methodology selected?
• How were comparable companies chosen?
• Are management forecasts supportable?
• What supports the discount for lack of marketability?
• Were material events around the valuation date appropriately considered?
• Does the capitalization table reconcile with the valuation model?
• Why did the common-stock value change from the previous 409A valuation?

For CFOs, controllers, founders, and finance teams, preparing for these questions in advance can make the review process significantly more efficient.

This guide examines 10 important areas that can attract scrutiny during a 409A valuation review and explains how companies can prepare stronger, audit-ready supporting documentation.

For companies that need independent valuation support, Synpact Consulting’s Valuation Services include 409A valuations supported by documented assumptions, valuation methodologies, financial modeling, sensitivity analysis, and audit-ready reporting.

What Is a 409A Valuation Audit Review?

A 409A valuation generally determines the fair market value of a private company’s common stock for purposes that can include establishing the exercise price of employee stock options.

Because shares of a privately held company generally do not have a readily observable public-market price, determining fair market value can require significant professional judgment.

A valuation review may therefore examine much more than the final common-stock value.

Depending on the circumstances, reviewers may evaluate:

• company financial information;
• recent financing transactions;
• management forecasts;
• capitalization data;
• valuation methodologies;
• comparable-company selection;
• market multiples;
• preferred-stock rights;
• equity-allocation methodologies;
• volatility assumptions;
• expected liquidity timing;
• discounts for lack of marketability; and
• events occurring around the valuation date.

An effective valuation should provide a logical and traceable path from the company’s underlying economics to the final common-stock value.

A simplified framework may look like:

Enterprise Value → Equity Value → Allocation Across Securities → Common Stock Value → Marketability Adjustment → Fair Market Value Per Share

Every significant step should be supported by appropriate analysis and documentation.

Why 409A Valuations Can Receive Significant Scrutiny

Private-company valuation frequently involves assumptions that cannot simply be observed from a stock exchange.

For example, a valuation specialist may need to determine:

• the appropriate valuation approach;
• the relevant public-company peer group;
• an appropriate valuation multiple;
• the reasonableness of management forecasts;
• the economic rights of different securities;
• expected volatility;
• time to a potential liquidity event;
• scenario probabilities; and
• an appropriate discount for lack of marketability.

The existence of professional judgment does not make a valuation unreliable.

However, the greater the judgment involved, the more important the supporting documentation becomes.

A reviewer should be able to understand:

1. what information was available as of the valuation date;
2. which methodologies were applied;
3. why those methodologies were appropriate;
4. which assumptions materially influenced value; and
5. how the analysis ultimately produced the common-stock FMV.

That brings us to the questions finance teams should be prepared to answer.

1. What Changed Since the Previous 409A Valuation?

One of the most fundamental questions during a review is also one of the easiest to overlook:

Why is the current common-stock value different from the previous 409A valuation?

Suppose the previous valuation concluded that common stock was worth $2.40 per share.

Nine months later, the updated valuation concludes $3.60 per share.

That represents a 50% increase.

A reviewer may reasonably want to understand the economic developments responsible for that movement.

Potential drivers could include:

• revenue or ARR growth;
• improved profitability;
• stronger gross margins;
• new customers;
• customer losses;
• changes in retention;
• a new financing round;
• changes in management forecasts;
• changes in public-company trading multiples;
• increased or reduced business risk;
• changes in cash runway;
• changes in the capital structure;
• secondary transactions; or
• movement toward a potential liquidity event.

The same analysis is important when the common-stock value declines.

How to Prepare

Create a clear valuation bridge between valuation dates.

Development	Potential Valuation Impact
Revenue exceeded prior forecast	Positive
New institutional financing	Potential positive valuation evidence
Public peer multiples declined	Negative
Cash runway improved	Positive
Expected liquidity timeline shortened	May affect marketability
Major customer lost	Potential negative
Forecast revised downward	Negative

The objective is not necessarily to attribute every cent of the change to a single factor.

Instead, management and the valuation specialist should be able to explain the economic story behind the movement in fair market value.

2. How Was the Latest Financing Round Considered?

A recent arm’s-length preferred-stock financing can represent important valuation evidence for a venture-backed company.

Assume institutional investors recently purchased Series C preferred shares at:

$12.00 per share

while the 409A valuation concludes that common stock is worth:

$5.25 per share.

A reviewer may ask:

Why is common stock worth significantly less than the preferred shares purchased by investors?

The answer should not simply be:

“Preferred stock is worth more than common stock.”

The actual economic rights of the securities need to be considered.

Preferred shares may contain features such as:

• liquidation preferences;
• conversion rights;
• participation features;
• dividend rights;
• seniority;
• protective provisions; and
• other contractual or economic rights.

Common stock may not have the same protections or economic characteristics.

Accordingly, the recent financing price should be analyzed within the context of the company’s actual capital structure.

How to Prepare

Maintain relevant financing documentation, including:

• financing term sheet;
• stock purchase agreement;
• amended charter;
• capitalization table;
• investor rights agreements;
• transaction date;
• preferred share price; and
• details of the rights associated with each security class.

When a financing occurs close to the valuation date, the valuation report should clearly explain how the transaction was considered and how value was allocated between preferred and common securities.

For a transaction-focused example, see Synpact’s 409A Valuation for a U.S. SaaS Startup After a Funding Round.

3. Why Was OPM, PWERM, or Another Allocation Method Selected?

Determining total equity value is only part of the valuation problem.

For venture-backed companies, that equity value may need to be allocated among:

• common stock;
• Series A preferred;
• Series B preferred;
• Series C preferred;
• employee options;
• warrants;
• convertible instruments; and
• other equity-linked securities.

Two methodologies commonly encountered in private-company equity allocation are the Option Pricing Method (OPM) and the Probability-Weighted Expected Return Method (PWERM).

The important review question is not simply whether the spreadsheet calculates correctly.

The reviewer may ask:

Why is the selected methodology appropriate for this company’s facts and circumstances as of the valuation date?

Option Pricing Method

OPM treats different classes of equity as having economic claims across different equity-value thresholds.

Depending on the analysis, relevant inputs may include:

• total equity value;
• liquidation preferences;
• conversion rights;
• volatility;
• expected time to liquidity;
• risk-free rate;
• dividend yield; and
• breakpoints within the capital structure.

Probability-Weighted Expected Return Method

PWERM explicitly considers potential future outcomes.

Scenarios might include:

• IPO;
• strategic acquisition;
• continued private operation;
• another financing;
• dissolution; or
• other company-specific outcomes.

Each scenario can require assumptions regarding:

• future enterprise or equity value;
• probability;
• timing;
• security rights; and
• allocation of proceeds.

Hybrid Methodologies

In some circumstances, a hybrid approach combining elements of OPM and PWERM may be appropriate.

How to Prepare

The report should explain why the selected allocation methodology reflects the company’s circumstances at the valuation date.

Methodology should follow the facts.

Using OPM simply because the company used OPM in the previous valuation is not, by itself, a sufficient analytical rationale. Companies with particularly complex capital structures may also require more sophisticated scenario or option-based analysis. Synpact’s Valuation & Advanced Modeling Services cover scenario trees, option-based valuation, integrated capital structure modeling, and other advanced techniques.

4. How Were Comparable Companies Selected?

Comparable-company selection can materially affect a private-company valuation.

A company may describe itself as a SaaS business, but that does not automatically make every publicly traded SaaS company an appropriate comparable.

Important differences can include:

• product offering;
• business model;
• customer profile;
• company size;
• revenue growth;
• gross margin;
• profitability;
• geography;
• recurring revenue;
• customer concentration;
• capital intensity; and
• maturity.

Consider a private SaaS company with:

• $15 million of ARR;
• 35% annual growth;
• negative EBITDA; and
• primarily enterprise customers.

A peer group dominated by mature, profitable software businesses growing at only 8% could require additional explanation.

How to Prepare

For each significant comparable company, the valuation analysis should be able to answer:

Why is this company relevant to the subject company?

It can also be important to document why seemingly similar companies were excluded.

The selected valuation multiple requires similar support.

For example, suppose comparable-company revenue multiples range from:

4.0x to 8.0x

and the subject company is valued using:

7.8x revenue.

A reviewer may ask why the company deserves valuation near the top of the range.

The explanation should connect the selected multiple to relevant factors such as:

• growth;
• profitability;
• gross margin;
• customer retention;
• market positioning;
• company-specific risk; and
• other relevant operating characteristics.

5. Are Management Forecasts Supportable?

A valuation model can be mathematically correct while still producing questionable results if the underlying forecasts are difficult to support.

Reviewers may compare:

• prior forecasts;
• historical results;
• current forecasts;
• board-approved budgets;
• investor presentations;
• management expectations; and
• actual performance following earlier valuation dates.

Suppose a valuation assumes that revenue will grow 70% during the next year, while the company’s board-approved budget assumes only 35%.

That difference deserves an explanation.

Questions Finance Teams Should Ask

Before the valuation is finalized:

• Did the company meet its previous forecast?
• If not, what caused the variance?
• Does the valuation use the forecast management actually relies upon?
• Is the forecast consistent with the board-approved budget?
• Are growth assumptions supported by pipeline or operating data?
• Are margin assumptions consistent with the company’s stage?
• Is the projected cash runway reasonable?
• Does the forecast assume additional financing?
• Were material forecast revisions made after the valuation date?

How to Prepare

Maintain version-controlled forecasts.

Clearly identify the forecast that existed and was considered appropriate as of the valuation date.

Where prior forecasts differed materially from actual performance, preserve an explanation of the variance.

This helps demonstrate that the valuation is based on information relevant to the measurement date rather than a later version of management’s expectations.

6. What Supports the Discount for Lack of Marketability?

Shares in a privately held company generally do not have the same liquidity as publicly traded securities.

When appropriate, a valuation may therefore incorporate a Discount for Lack of Marketability (DLOM).

However, a DLOM should not be treated as an arbitrary percentage.

A reviewer may ask:

• What methodology supports the DLOM?
• What expected holding period was assumed?
• What volatility assumption was used?
• What liquidity factors were considered?
• Did the DLOM change from the previous valuation?
• If so, what changed?
• Is the DLOM consistent with the company’s expected liquidity timeline?

These questions become particularly important when a company is approaching a potential:

• IPO;
• acquisition;
• secondary transaction; or
• other liquidity event.

How to Prepare

The valuation workpapers should document:

• methodology;
• data sources;
• volatility;
• expected liquidity horizon;
• company-specific factors; and
• rationale for the selected conclusion.

If the company is moving closer to a credible liquidity event, the assumptions used in the DLOM should also be consistent with assumptions elsewhere in the valuation.

7. Were Material Events Properly Considered?

A 409A valuation represents fair market value as of a specific valuation date.

Private companies, however, can change quickly.

Potentially important developments include:

• new financing rounds;
• signed financing term sheets;
• acquisition offers;
• secondary transactions;
• major customer wins;
• major customer losses;
• significant changes in forecasts;
• regulatory developments;
• major product launches;
• litigation;
• leadership changes;
• material changes in cash runway; or
• progress toward an IPO or sale.

A subsequent development can raise an important question:

Was this genuinely new information, or did it provide evidence about circumstances that already existed as of the valuation date?

How to Prepare

Maintain a timeline surrounding the valuation date.

For example:

March 31 — Valuation date
April 10 — Board approves revised forecast
April 22 — Financing term sheet received
May 15 — Financing closes

Then identify what information actually existed or was reasonably knowable as of March 31.

This contemporaneous record can make subsequent-event discussions easier to address.

Companies undergoing fundraising, secondary transactions, acquisitions, or other equity events may also require broader transaction analysis. Synpact’s Investment & Transaction Valuation Services cover startup funding, secondary share transactions, M&A, private equity, and other transaction-related valuation requirements.

8. Does the Capitalization Table Reconcile With the Valuation Model?

This may sound like a basic question.

It is also critical.

A technically sophisticated valuation model can still produce an incorrect per-share value if the underlying capitalization data is wrong.

Potential problems include:

• missing option grants;
• incorrect preferred shares outstanding;
• outdated option-pool information;
• unmodeled warrants;
• missing SAFEs;
• missing convertible securities;
• incorrect liquidation preferences;
• incorrect conversion ratios;
• duplicate securities; or
• inconsistent fully diluted share counts.

These errors can become particularly important when OPM or another equity-allocation model is used.

How to Prepare

Reconcile the valuation model against relevant records such as:

• legal capitalization table;
• equity-management platform;
• latest financing documents;
• certificate of incorporation;
• option plan;
• warrant agreements;
• SAFE or convertible agreements; and
• relevant board-approved grants.

The objective is straightforward:

Every security represented in the valuation model should reconcile to appropriate supporting documentation.

9. Are the Valuation Assumptions Internally Consistent?

Reviewers may evaluate assumptions not only individually but also collectively.

The entire valuation should tell a coherent economic story.

Consider a valuation that characterizes a company as extremely high risk but simultaneously assumes:

• aggressive revenue growth;
• rapid margin expansion;
• a valuation multiple near the top of the peer range;
• relatively low risk adjustments; and
• a short path to liquidity.

Each assumption might have support individually.

Together, however, they could appear inconsistent.

Another example involves a PWERM analysis that assigns significant probability to an IPO within 12 months while another part of the valuation assumes a substantially longer period of illiquidity.

That relationship may need to be reconciled.

How to Prepare

Perform a cross-assumption consistency review covering:

• management forecasts;
• comparable-company selection;
• selected market multiple;
• discount rate;
• volatility;
• time to liquidity;
• PWERM probabilities;
• OPM assumptions;
• DLOM;
• financing expectations; and
• company-specific risk.

A strong valuation should not consist of isolated assumptions.

The assumptions should work together to describe the same company, at the same valuation date, under the same economic circumstances.

10. Can the Final Common-Stock Value Be Reproduced and Defended?

Ultimately, a reviewer should be able to ask:

How did you get from the value of the business to this specific fair market value per common share?

And the valuation should provide a clear answer.

A simplified bridge may look like this:

Enterprise Value

↓

Plus Cash / Less Debt and Relevant Adjustments

↓

Equity Value

↓

Allocation Among Preferred and Common Securities

↓

Value Attributable to Common Stock

↓

Applicable Marketability Adjustment

↓

Fair Market Value Per Common Share

Every major stage should connect to identifiable data, calculations, or documented valuation assumptions.

A valuation becomes harder to review when a reviewer must repeatedly ask management or the valuation provider to reconstruct how the final number was produced.

Transparency should therefore be built into the valuation process from the beginning.

Representative 409A Valuation Review Example

Consider a hypothetical venture-backed SaaS company.

Company Profile

• ARR: $18 million
• Annual Growth: 40%
• EBITDA: Negative
• Latest Financing: Series B
• Series B Preferred Price: $10.00 per share
• Valuation Date: September 30
• Current 409A Common FMV: $4.20 per share
• Previous 409A Common FMV: $2.90 per share

The new common-stock FMV represents an increase of approximately 45%.

A reviewer asks:

Why did common-stock FMV increase materially?

A weak response would be:

“The company performed better.”

That statement does not provide enough analytical support.

A stronger valuation narrative might show that since the prior valuation:

• ARR increased materially;
• actual revenue exceeded the previous forecast;
• customer retention improved;
• cash runway increased;
• relevant public-company multiples increased;
• the probability of a favorable liquidity outcome increased; and
• expected time to liquidity shortened.

The valuation analysis could then demonstrate how those developments affected:

1. enterprise value;
2. equity value;
3. OPM or PWERM assumptions;
4. marketability considerations; and
5. final common-stock FMV.

The reviewer now has a traceable economic explanation rather than simply a new per-share number.

Documents to Prepare Before a 409A Valuation Review

Preparation can reduce unnecessary back-and-forth once review questions begin.

Corporate and Equity Documentation

Consider maintaining:

• current capitalization table;
• certificate of incorporation and amendments;
• preferred-stock rights;
• option plan documentation;
• option-grant records;
• warrant agreements;
• SAFE or convertible agreements; and
• relevant board materials.

Financing Documentation

Maintain relevant:

• stock purchase agreements;
• financing term sheets;
• investor rights agreements;
• secondary transaction information;
• investor presentations; and
• financing documentation.

Financial Information

Prepare:

• historical financial statements;
• latest management accounts;
• current budget;
• management forecasts;
• prior forecasts;
• actual-versus-budget analysis;
• cash information;
• debt information; and
• relevant operating KPIs.

Valuation Support

Maintain:

• comparable-company analysis;
• market data sources;
• valuation methodology support;
• volatility analysis;
• OPM or PWERM schedules;
• DLOM analysis;
• prior valuation reports;
• scenario and sensitivity analysis; and
• source information used as of the valuation date.

409A Pre-Review Checklist for CFOs and Finance Teams

Before delivering a valuation for external review, management can perform an internal quality check.

Valuation Date

• Is the valuation date correct?
• Is the analysis based on information appropriate to that date?
• Have potentially material subsequent developments been identified?

Financial Information

• Do historical financials reconcile to company records?
• Is the correct forecast version being used?
• Are significant forecast changes documented?
• Can management explain major historical forecast variances?

Financing

• Has the latest preferred financing been considered?
• Are preferred-stock rights modeled correctly?
• Have relevant secondary transactions been evaluated?

Capitalization

• Does the cap table reconcile?
• Are options and warrants appropriately reflected?
• Are SAFEs and convertible instruments addressed where applicable?
• Are liquidation preferences and conversion features modeled correctly?

Methodology

• Is methodology selection explained?
• Are OPM/PWERM assumptions supportable?
• Are scenario probabilities defensible where applicable?
• Is the methodology consistent with the company’s current stage?

Market Approach

• Are comparable companies genuinely relevant?
• Is peer selection documented?
• Are valuation multiples based on appropriate market data?
• Is the selected point within the range supported?

DLOM

• Is the methodology documented?
• Are volatility and holding-period assumptions supported?
• Is the conclusion consistent with expected liquidity timing?
• Can changes from the previous valuation be explained?

Reconciliation

• Can management explain the movement from the previous 409A?
• Does common-stock value reconcile to total equity value?
• Are major assumptions internally consistent?

Documentation

• Are important data sources retained?
• Are significant judgments documented?
• Can another qualified professional follow the analysis from inputs through conclusion?

If several of these questions cannot be answered clearly, addressing them before formal review may reduce delays later.

Common Mistakes That Create 409A Review Questions

Using a Stale Cap Table

Even a relatively small capitalization error can affect the final per-share value.

Automatically Carrying Forward the Previous Methodology

A methodology appropriate one year ago may not remain appropriate after a financing, acquisition offer, major growth milestone, or change in exit expectations.

Ignoring a Recent Financing

A significant arm’s-length transaction should be evaluated rather than omitted without explanation.

Using Weak Comparable Companies

Industry labels alone do not establish economic comparability.

Using an Overly Optimistic Forecast

Valuation assumptions should be supportable by information available at the valuation date.

Applying a Rule-of-Thumb DLOM

A percentage without a documented analytical basis may invite additional questions.

Failing to Explain Changes From the Previous Valuation

Reviewers should not have to reverse-engineer why FMV increased or decreased.

Mixing Information From Different Measurement Dates

The analysis should distinguish between information available at the valuation date and information that emerged later.

Using Inconsistent Assumptions

Forecasts, multiples, scenario probabilities, volatility, liquidity assumptions, and discounts should collectively tell a consistent economic story.

Weak Documentation

A potentially reasonable conclusion becomes substantially harder to defend when the underlying evidence cannot be identified or reproduced.

What Happens If a Reviewer Challenges the 409A Valuation?

A review question does not automatically mean the valuation conclusion is incorrect.

In many cases, the reviewer simply needs additional support for a methodology, assumption, or input.

A disciplined response can follow four steps.

Step 1: Identify the Exact Issue

Determine whether the question concerns:

• source data;
• methodology;
• assumption;
• calculation;
• documentation; or
• interpretation.

Step 2: Provide Existing Support

Before changing the model, identify the analysis and documentation supporting the original conclusion.

Step 3: Reassess if Necessary

If additional review identifies a factual, methodological, or modeling error, evaluate its impact systematically rather than making an isolated adjustment.

Step 4: Document the Resolution

Maintain a record of:

• the question raised;
• supporting information provided;
• additional analysis performed;
• any model changes;
• rationale for those changes; and
• final resolution.

This documentation can also improve the efficiency of subsequent valuation updates.

How to Make Future 409A Reviews Easier

The best time to prepare for review is before the valuation report is issued.

Companies can improve valuation readiness by maintaining:

• accurate capitalization records;
• consistent financial forecasts;
• board-approved budgets;
• financing documents;
• transaction timelines;
• current financial statements;
• historical valuation reports;
• supporting market data; and
• documentation of significant business developments.

The valuation provider can then incorporate those materials into an analysis designed to anticipate predictable review questions.

This becomes increasingly important as companies approach:

• significant fundraising;
• secondary share transactions;
• acquisitions;
• IPO preparation;
• complex capital structures; or
• more rigorous financial reporting requirements.

Audit-Ready 409A Valuation Is More Than a Per-Share Number

The quality of a 409A valuation should not be judged solely by whether it produces a common-stock FMV.

A robust analysis should also explain why that value is reasonable.

That means establishing a defensible relationship between:

• company performance;
• financial forecasts;
• market evidence;
• recent transactions;
• security rights;
• valuation methodology;
• equity allocation;
• marketability;
• company-specific risks; and
• the ultimate common-stock conclusion.

For companies requiring independent valuation analysis, Synpact Consulting’s Valuation Services support private companies, founders, investors, and finance teams across 409A and other complex valuation requirements.

When Should a Company Consider Specialist Valuation Support?

Specialist support may become particularly useful when:

• multiple preferred-stock classes exist;
• the company recently completed a financing;
• a secondary transaction has occurred;
• an acquisition or IPO is being considered;
• forecasts changed materially;
• common-stock FMV changed significantly;
• auditors or reviewers are questioning methodology;
• DLOM assumptions are receiving scrutiny;
• the capital structure contains complex instruments; or
• the internal finance team needs additional technical valuation capacity.

Where the issue extends beyond 409A into fundraising, secondary transactions, M&A, or exit planning, Synpact’s Investment & Transaction Valuation Services may also be relevant.

Frequently Asked Questions About 409A Valuation Audit Reviews

Does Every 409A Valuation Get Audited?

No. Whether and how a valuation is reviewed depends on the company’s circumstances and the context in which the valuation is being used.

A valuation may receive additional scrutiny in connection with financial reporting, stock-based compensation, transactions, due diligence, tax matters, or other professional review procedures.

What Is Typically Reviewed in a 409A Valuation?

Depending on the circumstances, areas of review can include:

• recent financing transactions;
• historical financial performance;
• management forecasts;
• valuation methodology;
• comparable companies;
• market multiples;
• capitalization;
• preferred-stock rights;
• equity-allocation methodology;
• DLOM;
• subsequent developments; and
• supporting documentation.

Why Can Common Stock Be Worth Less Than Preferred Stock?

Preferred securities may possess economic rights that common stock does not have.

Depending on the financing terms, these can include:

• liquidation preferences;
• seniority;
• conversion features;
• participation rights; and
• other contractual protections.

The valuation should analyze the actual rights of each security rather than applying an arbitrary discount between preferred and common stock.

Can Auditors Question OPM or PWERM?

Yes.

The important issue is not simply which methodology was used, but why that methodology was appropriate for the company’s facts and circumstances at the valuation date.

The assumptions within the selected methodology should also be supportable.

Why Is DLOM Important in a 409A Valuation?

Private-company shares generally lack the immediate liquidity available to publicly traded shares.

When a DLOM is applicable, assumptions regarding marketability, volatility, expected holding period, and potential liquidity can materially affect the common-stock conclusion.

The methodology and supporting assumptions should therefore be documented.

What Happens if a Financing Occurs Shortly After the 409A Valuation Date?

The circumstances should be evaluated carefully.

An important consideration is whether the later financing reflects genuinely new developments or provides information relevant to conditions that existed at the valuation date.

The facts and timeline surrounding the transaction matter.

For companies facing this situation, Synpact’s 409A Valuation for a U.S. SaaS Startup After a Funding Round provides a more transaction-focused discussion.

How Can a Company Prepare for a 409A Review?

Maintain organized and contemporaneous documentation, including:

• cap table;
• financing documents;
• historical financial statements;
• management forecasts;
• board-approved budgets;
• transaction information;
• prior valuation reports; and
• support for significant valuation assumptions.

The goal is to make the final valuation conclusion traceable and reproducible.

How Often Should a 409A Valuation Be Updated?

The appropriate timing depends on the company’s facts and circumstances, including the passage of time and whether material developments have occurred.

Financing rounds, significant business changes, secondary transactions, acquisition developments, or other material events may require the company and its advisers to reassess whether an existing valuation remains appropriate.

Can Synpact Support 409A Valuation Review Questions?

Yes. Synpact’s valuation practice includes 409A valuation and post-delivery support, with an emphasis on transparent methodology, documented assumptions, supporting schedules, and audit-ready reporting.

Companies with complex requirements can contact Synpact Consulting to discuss the appropriate valuation scope.

Final Takeaway

A strong 409A valuation review is not about predicting every question a reviewer might ask.

It is about building a valuation where the important questions already have well-supported answers.

Before finalizing a 409A valuation, management should be able to answer:

What changed since the previous valuation?

How was the latest financing considered?

Why was the valuation and allocation methodology selected?

Why are the selected comparable companies appropriate?

Are management forecasts supportable?

How was the DLOM determined?

Were material developments around the valuation date considered?

Does the cap table reconcile with the valuation model?

Are the assumptions internally consistent?

Can the final common-stock FMV be reproduced from the underlying analysis?

When the answers are supported by contemporaneous information, transparent methodology, and clear documentation, the valuation is better positioned for efficient professional review.

Need an Audit-Ready 409A Valuation?

Synpact Consulting provides valuation support for private companies, founders, investors, and finance professionals navigating complex valuation requirements.

Our valuation capabilities include 409A valuations, transaction valuations, financial modeling, complex capital structures, scenario analysis, and audit-ready documentation.

Explore Synpact Consulting’s Valuation Services

Contact Synpact Consulting to discuss your valuation requirements.